New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in…
First mRNA-based COVID 19 vaccine gets nod for phase II/III trial
New Delhi: The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India…